See the DrugPatentWatch profile for Cotempla
Cotempla is a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) in individuals aged 6 and older. It is a once-daily, extended-release formulation containing amphetamine [1].
How does Cotempla work for ADHD?
Cotempla XR-ODT (extended-release orally disintegrating tablets) works by increasing the levels of certain neurotransmitters, specifically dopamine and norepinephrine, in the brain [1]. These neurotransmitters play a role in attention, impulse control, and hyperactivity. By balancing these chemicals, Cotempla helps to manage the symptoms of ADHD.
What is the active ingredient in Cotempla?
The active ingredient in Cotempla is amphetamine [1]. Specifically, it is an extended-release formulation of mixed amphetamine salts.
How long does Cotempla take to work?
As an extended-release medication, Cotempla is designed to release its active ingredient gradually throughout the day. The full therapeutic effect may not be apparent immediately and can take some time to establish. Patients and healthcare providers typically monitor symptom improvement over a period of weeks.
What are the common side effects of Cotempla?
Common side effects associated with Cotempla include decreased appetite, insomnia, weight loss, dry mouth, abdominal pain, and increased blood pressure [1]. Less common but serious side effects can include cardiovascular problems, psychiatric issues, and growth suppression in children. It is crucial for patients to discuss any side effects with their doctor.
When does the patent for Cotempla expire?
Information regarding specific patent expiry dates for Cotempla is not readily available in the provided context. DrugPatentWatch.com is a resource that tracks pharmaceutical patents, including those for ADHD medications [2]. Patents for medications like Cotempla are crucial for protecting the manufacturer's investment and determining when generic versions may become available.
What are the alternatives to Cotempla for ADHD?
Besides Cotempla, other ADHD medications are available. These include other stimulant medications with different active ingredients or formulations, such as methylphenidate-based drugs. Non-stimulant medications are also an option for individuals who do not respond well to or cannot tolerate stimulants [3]. A healthcare professional can recommend the most suitable treatment based on an individual's needs and medical history.
How is Cotempla administered?
Cotempla is an orally disintegrating tablet (ODT) that can be taken with or without water. The tablet dissolves on the tongue and can be swallowed with saliva. It is typically taken once daily in the morning [1].
Sources:
[1] https://www.drugs.com/cotempla.html
[2] https://drugpatentwatch.com/
[3] https://www.additudemag.com/adhd-medication-treatment-options-for-adults-and-children/